News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ProImmune Limited Publishes White Paper 'Managing Immunogenicity Risk Through Assay-based Rational Drug Design and Selection'



11/23/2011 9:34:38 AM

OXFORD, England--(BUSINESS WIRE)--ProImmune Ltd., a leader in services for understanding immune responses, has published a white paper on the effective management of immunogenicity risk in the design of biologics. The document addresses issues including how to manage immunogenicity effectively, improvement of drugs through better rational design methods, and what can be learned from measuring T cell responses at the preclinical stage.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES